Treatment outcome of extra-pulmonary tuberculosis in Finland: A cohort study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Vasankari, Tuula ^a,b   Holmström, Pekka ^a   Ollgren, Jukka ^a   Liippo, Kari ^b   Ruutu, Petri ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

AGE; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; FEMALE; FINLAND; HUMAN; IMMUNOCOMPROMISED PATIENT; MALE; MIDDLE AGED; MORTALITY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; TREATMENT OUTCOME; TUBERCULOSIS;

AGE FACTORS; AGED; ANTITUBERCULAR AGENTS; COHORT STUDIES; COMORBIDITY; FEMALE; FINLAND; HUMANS; IMMUNOCOMPROMISED HOST; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 77955129577     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-399     Document Type: Article

References (29)

1. WHO Tuberculosis Programme: framework for effective tuberculosis control. World Health Organization, World Health Organization Document World Health Organization, Geneva 1994 WHO/TB/94.179
2. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group. JF Broekmans GB Migliori HL Rieder J Lees P Ruutu R Loddenkemper, et al. Eur Respir J 2002 19 4 765 775 World Health Organization International Union Against Tuberculosis and Lung Disease and Royal Netherlands Tuberculosis Association Working Group 10.1183/09031936.02.00261402 11999007
3. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working group of the World Health organisation (WHO) and the European Region of the International Union against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. J Veen M Raviglione HL Rieder GB Migliori P Graf M Grzemska, et al. Eur Respir J 1998 12 505 510 10.1183/09031936.98.12020505 9727811
4. Revised international definitions in tuberculosis control. WHO IUATLD and KNCV, Int J Tuberc Lung Dis 2001 5 3 213 215 11326818
5. EuroTB. Definitions for the WHO/EuroTB Joint Tuberculosis Data Collection. 2007 http://www.eurotb.org/data-collection/english/Definitions- joint-TB-data-collection-form-2007.doc
6. Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992. T Lillebaek S Poulsen A Kok-Jensen, Int J Tuberc Lung Dis 1999 3 7 603 612 10423223
7. Current status of treatment completion and fatality among tuberculosis patients in Spain. JA Cayla JA Caminero R Rey N Lara X Valles H Galdos-Tanguis Working Group on Completion of Tuberculosis Treatment in Spain, Int J Tuberc Lung Di 2004 8 4 458 464
8. Outcome of patients treated for tuberculosis in Vaud County, Switzerland. JP Zellweger P Coulon, Int J Tuberc Lung Dis 1998 2 5 372 377 9613632
9. Outcome of pulmonary tuberculosis treatment in the tertiary care setting -Toronto 1992/93. W Wobeser L Yuan M Naus Tuberculosis Treatment Completion Study Group, CMAJ: Canadian Medical Association Journal 1999 160 6 789 794
10. Progress and problems in achieving the United States national target for completion of antituberculosis treatment. DP Chin KC Cummings S Sciortino DC Snyder LF Johnson JL Westenhouse SE Royce, Int J Tuberc Lung Dis 2000 4 8 744 751 10949326
11. Evaluation of tuberculosis treatment results in Italy, report 1998. Tuberculosis section of the National AIPO Study Group on Infectious Disease and the SMIRA Group. R Centis A Ianni GB Migliori, Monaldi Arch Chest Dis 2000 55 4 293 298 11057082
12. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000. LP Ormerod N Horsfield RM Green, Int J Tuberc Lung Dis 2002 6 8 662 665 12150476
13. Is quarterly cohort analysis useful for assessing treatment outcomes in a low incidence country? L Trnka D Dakova F Krejbich, Int J Tuberc Lung Dis 2001 5 3 250 256 11326824
14. Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. P Helbling C Medinger E Altpeter PA Raeber D Beeli JP Zellweger, Swiss Med Wkly 2002 132 35-36 517 522 12506334
15. The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998. LP Ormerod RJ Prescott, Clin Med 2003 3 1 57 61 12617417
16. Tuberculosis treatment outcomes in Europe: a systematic review. A Faustini AJ Hall CA Perucci, Eur Respir J 2005 26 503 510 10.1183/09031936.05. 00103504 16135735
17. Treatment outcome of new culture positive pulmonary tuberculosis in Norway. M Farah A Tverdall T Steen E Heldall A Brantsaeter G Bjune, BMC Public Health 2005 5 14 10.1186/1471-2458-5-14 15698472
18. Great diversity of tuberculosis treatment in Finland. T Vasankari M Kokki P Holmström K Liippo S Sarna P Ruutu, Euro Surveill 2007 12 17 21
19. Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2006. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region, Institut de veille sanitaire, Saint-Maurice, France 2008
20. Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. IC Ditah M Reacher C Palmer JM Watson J Innes ME Kruijshaar HN Luma I Abubakar, Thorax 2008 63 440 446 10.1136/thx.2006.073916 17615085
21. High sensivity for tuberculosis in a laboratory-based national integrated infectious disease surveillance system in Finland. M Kokki P Holmström P Ruutu, Euro Surveill 2005 10 90 93 16077215
22. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. T Vasankari P Holmström J Ollgren K Liippo M Kokki P Ruutu, BMC Public Health 2007 7 291 10.1186/1471-2458-7-291 17935630
23. Tuberkuloosi ja sen lääkehoito. Lääkintö hallitus, Kapseli 1985 Finnish National Board of Health. Tuberculosis and its treatment 15 Lääkintöhallituksen julkaisu (in Finnish)
24. Guidelines for tuberculosis treatment in adults and children in National Tuberculosis Programmes. World Health Organization Tuberculosis Unit Division of Communicable Disease, 161 WHO/TB/91
25. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society, Am Rev Resp Dis 1986 134 355 363 3527010
26. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations. Joint Tuberculosis Committee of the British Thoracic Society, Thorax 1990 45 403 408 10.1136/thx.45.5.403 2382247
27. Clinical tuberculosis. PDO Davies, London, MacMillan Education 1994
28. Tuberkuloosin lääkehoito ja -profylaksia. Tuberculosis treatment and prophylaxis. E Tala, Duodecim 1993 109 69 75 in Finnish 8013311
29. Exploring the determinants of treatment success for tuberculosis cases in Europe. D Falzon Y Le Strat F Belghiti A Infuso EuroTB Correspondents, Int J Tuberc Lung Dis 2005 9 1224 1229 16333929